Acute and Chronic Gout Management

Acute Gout Attack Management

The American College of Rheumatology recommends colchicine as a first-line treatment option for acute gout attacks, with the most effective regimen being a low-dose of 1.2 mg followed by 0.6 mg one hour later, started within 12 hours of symptom onset 2, 3
The American College of Rheumatology suggests NSAIDs at full anti-inflammatory doses, such as naproxen 500 mg twice daily, as an effective treatment option when started promptly 1, 4
Oral corticosteroids, such as prednisolone 30-35 mg daily for 3-5 days, are recommended for patients with contraindications to NSAIDs or colchicine 1, 3
Intra-articular corticosteroid injection is an effective option for single joint involvement 2, 5

The American College of Rheumatology recommends xanthine oxidase inhibitors, such as allopurinol or febuxostat, as first-line options for long-term management of gout 2
Uricosuric agents, such as probenecid or benzbromarone, can be used as alternatives in patients with normal renal function 7
Anti-inflammatory prophylaxis is strongly recommended when starting urate-lowering therapy to prevent flares, with options including low-dose colchicine, low-dose NSAIDs, or low-dose prednisone 2, 6
Prophylaxis should be continued for at least 6 months, or 3 months after achieving target serum urate if no tophi are present, or 6 months after achieving target serum urate if tophi are present 6

Failing to start treatment early can lead to poor outcomes, and acute gout should be treated as soon as possible for best results 3
Discontinuing urate-lowering therapy during acute flares should be avoided 5
Inadequate duration of prophylaxis when initiating urate-lowering therapy can lead to breakthrough flares 6
Drug interactions, particularly with colchicine, should be considered to avoid serious toxicity 3